Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review.

Chi-Yang Chang, Han-Mo Chiu, Yi-Chia Lee, Shih-Pei Huang, Min-Fong Chen, Jaw-Town Lin, Low efficacy of serum levels of CA 19-9 in prediction of malignant diseases in asymptomatic population in Taiwan Hepato-gastroenterology. ,vol. 53, pp. 1- 4 ,(2006)

Hiromitsu Saisho, Seiki Matsuno, Osamu Ishikawa, Hiroshi Ishii, Jyunji Furuse, Hideyuki Wakasugi, Tosiya Sato, Shinji Yokoyama, Shuichi Okada, CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer Hepato-gastroenterology. ,vol. 44, pp. 279- 283 ,(1997)

Mark Sausen, Jillian Phallen, Vilmos Adleff, Siân Jones, Rebecca J Leary, Michael T Barrett, Valsamo Anagnostou, Sonya Parpart-Li, Derek Murphy, Qing Kay Li, Carolyn A Hruban, Rob Scharpf, James R White, Peter J O’Dwyer, Peter J Allen, James R Eshleman, Craig B Thompson, David S Klimstra, David C Linehan, Anirban Maitra, Ralph H Hruban, Luis A Diaz Jr, Daniel D Von Hoff, Julia S Johansen, Jeffrey A Drebin, Victor E Velculescu, None, Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients Nature Communications. ,vol. 6, pp. 7686- 7686 ,(2015) , 10.1038/NCOMMS8686

Umashankar K Ballehaninna, Ronald S Chamberlain, The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of gastrointestinal oncology. ,vol. 3, pp. 105- 119 ,(2012) , 10.3978/J.ISSN.2078-6891.2011.021

Hideaki Kinugasa, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Chihiro Dohi, Koichiro Tsutsumi, Hironari Kato, Takehiro Matsubara, Hiroyuki Okada, Kazuhide Yamamoto, Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer. Cancer. ,vol. 121, pp. 2271- 2280 ,(2015) , 10.1002/CNCR.29364

JEE-EUN KIM, KYU TAEK LEE, JONG KYUN LEE, SEUNG WOON PAIK, JONG CHUL RHEE, KYOO WAN CHOI, Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population Journal of Gastroenterology and Hepatology. ,vol. 19, pp. 182- 186 ,(2004) , 10.1111/J.1440-1746.2004.03219.X

Thomas Semrad, Afsaneh Barzi, Heinz-Josef Lenz, Irene M. Hutchins, Edward J. Kim, I-Yeh Gong, Michael Tanaka, Laurel Beckett, William Holland, Rebekah A. Burich, Leslie Snyder-Solis, Philip Mack, Primo N. Lara, Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results International Journal of Clinical Oncology. ,vol. 20, pp. 518- 524 ,(2015) , 10.1007/S10147-014-0730-2

F Maire, S Micard, P Hammel, H Voitot, P Lévy, P-H Cugnenc, P Ruszniewski, P Laurent Puig, Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. British Journal of Cancer. ,vol. 87, pp. 551- 554 ,(2002) , 10.1038/SJ.BJC.6600475

H. Moriyama, N. Matsubara, T. Kanbara, M. Mori, J. Matsuoka, T. Yoshino, N. Takakura, K. Shimizu, N. Takaka, Allelic imbalance and microsatellite instability in plasma DNA released from polyclonal pancreatic adenocarcinoma International Journal of Oncology. ,vol. 21, pp. 949- 956 ,(2002) , 10.3892/IJO.21.5.949

H. Chen, H. Tu, Z.Q. Meng, Z. Chen, P. Wang, L.M. Liu, K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer Ejso. ,vol. 36, pp. 657- 662 ,(2010) , 10.1016/J.EJSO.2010.05.014